Tag - dementia

 
 

DEMENTIA

When the effects of dementia cause Yohji (left, Tatsuya Fuji) to spiral out of control, it becomes clear to his son (Mirai Moriyama) that he has been absent from his life in more ways than one in Kei Chikaura’s “Great Absence.”
CULTURE / Film
Jul 11, 2024
‘Great Absence’: Poetic family drama follows downfall of dementia-plagued patriarch
A retired professor’s mind is slipping away from him, but there is more to unravel in Kei Chikaura’s dark family drama.
Municipalities across the country have been devising various ways to keep track of the whereabouts of individuals with dementia.
JAPAN / Society
Jul 5, 2024
Record 19,000 people with dementia reported missing in Japan in 2023
The figure is nearly twice that of a decade earlier, according to the National Police Agency.
About 1 to 1.8 out of 1,000 people in Japan are diagnosed with Parkinson’s disease.
JAPAN / Science & Health
Jun 6, 2024
Japan researchers develop drug to visualize Parkinson’s disease in living patients
The study could help better our understanding of such neurodegenerative diseases, for which there are currently no cures.
Artificial intelligence is being utilized to detect dementia at an early stage, such as through analyzing characteristics seen in the way people with dementia walk.
JAPAN / Science & Health
Jun 5, 2024
AI tools to detect dementia under development in Japan
The health ministry thinks that about 11.97 million people will have dementia or mild cognitive impairment in Japan in 2040.
Researchers at Tokyo's Juntendo University investigated whether an SGLT2 inhibitor, a drug that promotes sugar excretion through urine, could remove aging cells by administering it to obese mice for a week.
JAPAN / Science & Health
May 31, 2024
Diabetes drug shows promise for aging-related illnesses in mice study
The Juntendo University study shows an SGLT2 inhibitor successfully eliminating senescent cells, which accumulate with age, in the mice's visceral fat.
The latest findings by University of Tokyo researchers raise hopes that the disease may be treated if doctors can identify people who will develop Alzheimer’s before its onset.
JAPAN / Science & Health
May 23, 2024
Japanese researchers confirm blood test predicts risk of Alzheimer's
The latest study raises hopes that if doctors can identify who might be at risk of developing Alzheimer’s beforehand, it could be treated early.
The latest figure is significantly less than a previous projection released in 2015 that said more than 8 million people would have dementia by 2040.
JAPAN / Science & Health
May 8, 2024
Nearly 6 million elderly people in Japan will have dementia by 2040
While the figure is lower than a previous projection, the latest estimate still showed a steady growth in the number of people with dementia.
While a new Alzheimer’s test offers hope for early intervention, it also raises complex ethical and practical questions about its implementation and potential impact on individuals' lives.
COMMENTARY / World
May 5, 2024
Do you really want to find out if you'll get Alzheimer's?
Would you want to know there’s something going wrong in your brain — even if there’s no cure?
Tests for patients suffering from Alzheimer's disease. According to the Alzheimer's Association, the disease is estimated to affect more than 6 million Americans.
WORLD / Science & Health / FOCUS
Apr 24, 2024
Alzheimer's drug adoption in U.S. slowed by doctors' skepticism
There is an entrenched belief among some doctors that treating the memory-robbing disease is futile.
The new Alzheimer's drug lecanemab, branded Leqembi
JAPAN
Dec 13, 2023
New Alzheimer's drug to be covered by health insurance in Japan
The drug, to be launched Dec. 20, will cost around ¥2.98 million per year in Japan but patients will only have to pay a limited share.
A research has found that hexaraphane — a component found in wasabi — helps improve the episodic and working memories of elderly people.
JAPAN / Science & Health
Nov 26, 2023
Wasabi effective in improving memory of elderly: study
In addition to known antioxidant and anti-inflammatory effects, new research indicates improvements in episodic and working memories.
AI software is being used to detect cognitive decline in older Japanese drivers in order to help prevent accidents.
BUSINESS / Tech
Oct 22, 2023
AI startup helps insurers spot cognitive decline in elderly drivers
Once reliant on a driver's age and model of car, some insurers now rely on AI to expedite settlements and craft more precise risk assessments.
Elderly people experience taking part in esports in Ono, Fukushima Prefecture.
JAPAN / Science & Health / Regional Voices: Fukushima
Oct 16, 2023
Fukushima town turns to esports as a health tool for the elderly
Ono and Fukushima Medical University have been holding trial sessions and analyzing the effects of gaming experience on cognitive functions.
A 93-year-old at his office in Tokyo solves ancient math problems in Egyptian numbers to keep his mind sharp.
JAPAN / Science & Health
Oct 3, 2023
Japan prepares national project to deal with dementia
About 9.53 million people, or 1 in 4 elderly people, are predicted to have dementia in 2040.
An elderly person plays a racing video game in 2022 to ward off dementia.
JAPAN / Science & Health
Sep 25, 2023
As Japan OKs Alzheimer's drug, issue of side effects comes into focus
There are big challenges ahead for the use of lecanemab, particularly on how to control side effects such as brain swelling and bleeding.
Shinobu Yamanaka, a mom of three sons and director of a day care facility in Konan, Kochi Prefecture, serves up to eight "members" six days a week.
JAPAN / Science & Health / FOCUS
Aug 22, 2023
Kochi dementia care center aims to set new paradigm in Japan
A new generation of people with Alzheimer’s in Japan are trying to change not only dementia care but also social attitudes toward patients.
Packages of lecanemab, marketed as Leqembi, for the U.S. market
JAPAN / Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer’s drug lecanemab
The panel’s endorsement will be followed by official approval by the health minister in coming days.
Japan Times
WORLD / Science & Health
Jul 17, 2023
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
New guidelines would replace terminology such as mild, moderate and severe, instead using a numerical system related to disease progression.
Japan Times
BUSINESS / Companies
Jul 11, 2023
Eisai appoints CEO’s son to lead global Alzheimer drug program
Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.
Japan Times
WORLD / Science & Health
Jul 7, 2023
Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy
The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'